140 related articles for article (PubMed ID: 37867242)
1. Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform.
Shi PD; Xu YP; Zhu Z; Zhou C; Wu M; He Y; Zhao H; Liu L; Zhao L; Li XF; Qin CF
Adv Sci (Weinh); 2023 Nov; 10(33):e2303615. PubMed ID: 37867242
[TBL] [Abstract][Full Text] [Related]
2. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.
Dhakal S; Loube J; Misplon JA; Lo CY; Creisher PS; Mulka KR; Deshpande S; Mitzner W; Klein SL; Epstein SL
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627390
[TBL] [Abstract][Full Text] [Related]
3. rM2e-ΔPly protein immunization induces protection against influenza viruses and its co-infection with Streptococcus pneumoniae in mice.
Guo T; Xiao J; Li L; Xu W; Yuan Y; Yin Y; Zhang X
Mol Immunol; 2022 Dec; 152():86-96. PubMed ID: 36306645
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
[TBL] [Abstract][Full Text] [Related]
5. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
[TBL] [Abstract][Full Text] [Related]
6. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against swine influenza in pigs causes different drift evolutionary patterns upon swine influenza virus experimental infection and reduces the likelihood of genomic reassortments.
López-Valiñas Á; Valle M; Wang M; Darji A; Cantero G; Chiapponi C; Segalés J; Ganges L; Núñez JI
Front Cell Infect Microbiol; 2023; 13():1111143. PubMed ID: 36992684
[TBL] [Abstract][Full Text] [Related]
8. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
9. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.
Hemann EA; Kang SM; Legge KL
J Immunol; 2013 Sep; 191(5):2486-94. PubMed ID: 23885108
[TBL] [Abstract][Full Text] [Related]
10. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
12. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
[No Abstract] [Full Text] [Related]
13. Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies.
Keating R; Johnson JL; Brice DC; Labombarde JG; Dent AL; McGargill MA
mBio; 2020 Nov; 11(6):. PubMed ID: 33144374
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.
Driver JP; de Carvalho Madrid DM; Gu W; Artiaga BL; Richt JA
Front Immunol; 2020; 11():2172. PubMed ID: 33193296
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.
Nogales A; DeDiego ML; Martínez-Sobrido L
Front Cell Infect Microbiol; 2022; 12():954811. PubMed ID: 35937688
[TBL] [Abstract][Full Text] [Related]
16. Understanding immunity to influenza: implications for future vaccine development.
Tripp RA
Expert Rev Vaccines; 2023; 22(1):871-875. PubMed ID: 37794732
[TBL] [Abstract][Full Text] [Related]
17. Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.
Oltean T; Ibanez LI; Divert T; Ysenbaert T; Van Eeckhoutte H; Goossens V; Schotsaert M; Bracke K; Schepens B; Maelfait J; Takahashi N; Saelens X; Vandenabeele P
Cell Death Dis; 2022 Mar; 13(3):280. PubMed ID: 35351865
[TBL] [Abstract][Full Text] [Related]
18. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.
Sakai K; Ami Y; Tahara M; Kubota T; Anraku M; Abe M; Nakajima N; Sekizuka T; Shirato K; Suzaki Y; Ainai A; Nakatsu Y; Kanou K; Nakamura K; Suzuki T; Komase K; Nobusawa E; Maenaka K; Kuroda M; Hasegawa H; Kawaoka Y; Tashiro M; Takeda M
J Virol; 2014 May; 88(10):5608-16. PubMed ID: 24600012
[TBL] [Abstract][Full Text] [Related]
19. Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.
Harding AT; Heaton BE; Dumm RE; Heaton NS
mBio; 2017 Jun; 8(3):. PubMed ID: 28588131
[TBL] [Abstract][Full Text] [Related]
20. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
